NCT01798784已完成不适用
Testing Behavioral Economic Interventions to Improve Statin Use and Reduce CVD Risk
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 805
- 试验地点
- 2
- 主要终点
- Change in LDL from baseline to 12 months
研究概览
简要总结
In a 4-arm, Randomized Control Trial among members of CVS Caremark or Penn Medicine Patients with suboptimal cholesterol control who are at high risk for CVD, the study investigators propose to test the effectiveness of different behavioral economic techniques in inducing habit formation for adherence to statin use and sustained reductions in LDL cholesterol after financial incentives are discontinued. Primary outcome is changes in LDL from enrollment to 12 months (6 months after cessation of financial incentives).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Individuals at high risk of a cardiac event, specifically one of the following:
- •Individuals with clinical CVD (defined as diagnosis with myocardial infarction, stroke, or peripheral vascular disease) with an LDL greater than or equal to 100 mg/dl ;
- •Individuals with Diabetes (between the ages of 40-75) with an LDL greater than or equal to 100 mg/dl;
- •Individuals without clinical CVD or diabetes with LDL greater than or equal to 100 mg/dl and estimated 10-year CVD risk 7.5%;
- •Individuals without clinical CVD or diabetes with LDL cholesterol greater than or equal to 190 mg/dl A prescription filled for a statin medication within the last 12 months (derived from pharmacy records);
- •Medication Possession Ratio (MPR) less than or equal to 80%
- •Low medication adherence on self-report completed during enrollment
排除标准
- •Less than 18 years old
- •Contraindication to further statin use or have suffered side effects from statins, such as myopathy
- •Will not or cannot give consent
- •History of active or progressive liver disease or abnormal liver function tests on baseline screening when applicable
- •Currently participating in another clinical trial with related aims
- •Co-morbidities likely to lead to death within a short-period
结局指标
主要结局
Change in LDL from baseline to 12 months
时间窗: 12 months
次要结局
- Statin Adherence 6 months after active phase of intervention(6 months)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
A Trial of Behavioral Economic Interventions to Reduce Cardiovascular Disease (CVD) RiskCardiovascular DiseaseNCT01346189University of Pennsylvania1,503
已完成
不适用
A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid PrescribingAcute PainNCT03825549University of Pennsylvania452
已完成
不适用
Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in MenHuman Immunodeficiency VirusAcquired Immunodeficiency SyndromeSexually Transmitted Diseases, ViralRetroviridae InfectionsVirus DiseasesVirus-HIVRNA Virus InfectionsHIV InfectionsNCT04772469University of California, San Francisco934
已完成
不适用
GlowCaps Adherence Randomized Control TrialMedical AdherenceNCT01756001University of Pennsylvania119
已完成
不适用
The Healthy Weigh StudyObesityNCT02878343University of Pennsylvania344